These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

223 related articles for article (PubMed ID: 18755577)

  • 21. Methamphetamine Induces Dopamine Release in the Nucleus Accumbens Through a Sigma Receptor-Mediated Pathway.
    Hedges DM; Obray JD; Yorgason JT; Jang EY; Weerasekara VK; Uys JD; Bellinger FP; Steffensen SC
    Neuropsychopharmacology; 2018 May; 43(6):1405-1414. PubMed ID: 29185481
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Role of tumor necrosis factor-alpha in methamphetamine-induced drug dependence and neurotoxicity.
    Nakajima A; Yamada K; Nagai T; Uchiyama T; Miyamoto Y; Mamiya T; He J; Nitta A; Mizuno M; Tran MH; Seto A; Yoshimura M; Kitaichi K; Hasegawa T; Saito K; Yamada Y; Seishima M; Sekikawa K; Kim HC; Nabeshima T
    J Neurosci; 2004 Mar; 24(9):2212-25. PubMed ID: 14999072
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Methamphetamine-induced neurotoxicity in BALB/c, DBA/2N and C57BL/6N mice.
    Kita T; Paku S; Takahashi M; Kubo K; Wagner GC; Nakashima T
    Neuropharmacology; 1998 Sep; 37(9):1177-84. PubMed ID: 9833648
    [TBL] [Abstract][Full Text] [Related]  

  • 24. SN79, a sigma receptor antagonist, attenuates methamphetamine-induced astrogliosis through a blockade of OSMR/gp130 signaling and STAT3 phosphorylation.
    Robson MJ; Turner RC; Naser ZJ; McCurdy CR; O'Callaghan JP; Huber JD; Matsumoto RR
    Exp Neurol; 2014 Apr; 254():180-9. PubMed ID: 24508558
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Sigma1 receptor antagonists determine the behavioral pattern of the methamphetamine-induced stereotypy in mice.
    Kitanaka J; Kitanaka N; Tatsuta T; Hall FS; Uhl GR; Tanaka K; Nishiyama N; Morita Y; Takemura M
    Psychopharmacology (Berl); 2009 May; 203(4):781-92. PubMed ID: 19052726
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Methamphetamine-induced dopamine transporter complex formation and dopaminergic deficits: the role of D2 receptor activation.
    Hadlock GC; Chu PW; Walters ET; Hanson GR; Fleckenstein AE
    J Pharmacol Exp Ther; 2010 Oct; 335(1):207-12. PubMed ID: 20622144
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Dopamine uptake blockers nullify methamphetamine-induced decrease in dopamine uptake and plasma membrane potential in rat striatal synaptosomes.
    Westphalen RI; Stadlin A
    Ann N Y Acad Sci; 2000 Sep; 914():187-93. PubMed ID: 11085320
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Mechanisms underlying methamphetamine-induced dopamine transporter complex formation.
    Hadlock GC; Baucum AJ; King JL; Horner KA; Cook GA; Gibb JW; Wilkins DG; Hanson GR; Fleckenstein AE
    J Pharmacol Exp Ther; 2009 Apr; 329(1):169-74. PubMed ID: 19141713
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Methamphetamine-induced dopaminergic neurotoxicity in mice: long-lasting sensitization to the locomotor stimulation and desensitization to the rewarding effects of methamphetamine.
    Itzhak Y; Martin JL; Ali SF
    Prog Neuropsychopharmacol Biol Psychiatry; 2002 Oct; 26(6):1177-83. PubMed ID: 12452543
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Effect of temperature on dopamine transporter function and intracellular accumulation of methamphetamine: implications for methamphetamine-induced dopaminergic neurotoxicity.
    Xie T; McCann UD; Kim S; Yuan J; Ricaurte GA
    J Neurosci; 2000 Oct; 20(20):7838-45. PubMed ID: 11027249
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Rimcazole analogs attenuate the convulsive effects of cocaine: correlation with binding to sigma receptors rather than dopamine transporters.
    Matsumoto RR; Hewett KL; Pouw B; Bowen WD; Husbands SM; Cao JJ; Newman AH
    Neuropharmacology; 2001 Dec; 41(7):878-86. PubMed ID: 11684152
    [TBL] [Abstract][Full Text] [Related]  

  • 32. M100907 and BD 1047 attenuate the acute toxic effects of methamphetamine.
    Ray A; Canal CE; Ehlen JC; Rice KC; Murnane KS
    Neurotoxicology; 2019 Sep; 74():91-99. PubMed ID: 31163210
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Single and binge methamphetamine administrations have different effects on the levels of dopamine D2 autoreceptor and dopamine transporter in rat striatum.
    Chauhan H; Killinger BA; Miller CV; Moszczynska A
    Int J Mol Sci; 2014 Apr; 15(4):5884-906. PubMed ID: 24717411
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Mithramycin protects against dopaminergic neurotoxicity in the mouse brain after administration of methamphetamine.
    Hagiwara H; Iyo M; Hashimoto K
    Brain Res; 2009 Dec; 1301():189-96. PubMed ID: 19748494
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Changes in neural circuitry regulating response-reversal learning and Arc-mediated consolidation of learning in rats with methamphetamine-induced partial monoamine loss.
    Pastuzyn ED; Keefe KA
    Neuropsychopharmacology; 2014 Mar; 39(4):963-72. PubMed ID: 24150570
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Escalating dose methamphetamine pretreatment alters the behavioral and neurochemical profiles associated with exposure to a high-dose methamphetamine binge.
    Segal DS; Kuczenski R; O'Neil ML; Melega WP; Cho AK
    Neuropsychopharmacology; 2003 Oct; 28(10):1730-40. PubMed ID: 12865898
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Neuronal dopamine transporter activity, density and methamphetamine inhibition are differentially altered in the nucleus accumbens and striatum with no changes in glycosylation in rats behaviorally sensitized to methamphetamine.
    Bjorklund NL; Sorg BA; Schenk JO
    Synapse; 2008 Oct; 62(10):736-45. PubMed ID: 18651643
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Epothilone D prevents binge methamphetamine-mediated loss of striatal dopaminergic markers.
    Killinger BA; Moszczynska A
    J Neurochem; 2016 Feb; 136(3):510-25. PubMed ID: 26465779
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Chronic stress enhances methamphetamine-induced extracellular glutamate and excitotoxicity in the rat striatum.
    Tata DA; Yamamoto BK
    Synapse; 2008 May; 62(5):325-36. PubMed ID: 18288648
    [TBL] [Abstract][Full Text] [Related]  

  • 40. The sigma receptor agonist SA4503 both attenuates and enhances the effects of methamphetamine.
    Rodvelt KR; Oelrichs CE; Blount LR; Fan KH; Lever SZ; Lever JR; Miller DK
    Drug Alcohol Depend; 2011 Jul; 116(1-3):203-10. PubMed ID: 21277708
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 12.